(Q80439455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Improvement in the handling of drug-drug interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

Uwe Fuhr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

3 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

167-171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18172623%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-007-0436-8

31 December 2019

exact match

0 references

cites work

High-throughput lead finding and optimisation for GPCR targets

1 reference

12 December 2020

Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.

1 reference

12 December 2020

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability

1 reference

12 December 2020

Gemfibrozil greatly increases plasma concentrations of cerivastatin

1 reference

12 December 2020

Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.

1 reference

12 December 2020

Strategies to reduce late-stage drug attrition due to mitochondrial toxicity

1 reference

12 December 2020

Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid

1 reference

12 December 2020

Reasons provided by prescribers when overriding drug-drug interaction alerts

1 reference

12 December 2020

Lack of pharmacokinetic interaction as an equivalence problem

1 reference

12 December 2020

Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study

1 reference

12 December 2020

Drug interactions. Mechanisms and clinical relevance

1 reference

12 December 2020

Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands

1 reference

12 December 2020

The actions and interactions of drugs: the therapeutic significance of enzyme induction

1 reference

12 December 2020

Polypharmacy in the elderly: a literature review

1 reference

12 December 2020

1 reference

12 December 2020

Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam

1 reference

12 December 2020

Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin

1 reference

12 December 2020

A new cytochrome in liver microsomes

1 reference

12 December 2020

Griseofulvin-Phenobarbital Interaction in Man

1 reference

12 December 2020

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

1 reference

12 December 2020

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

12 December 2020

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

1 reference

12 December 2020

Systematic screening for pharmacokinetic interactions during drug development

1 reference

12 December 2020

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

1 reference

12 December 2020

Prediction of maximum exposure in poor metabolizers following inhibition of nonpolymorphic pathways.

1 reference

12 December 2020

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions

1 reference

12 December 2020

What is the true risk of a pharmacokinetic drug-drug interaction?

1 reference

12 December 2020

[Experimental studies in humans on the synergistic action of prednisolone and phenylbutazone]

1 reference

12 December 2020

Polypharmacy and hospitalization among older home care patients

1 reference

12 December 2020

Cytochrome P-450 of liver microsomes--one pigment or many

1 reference

12 December 2020